Literature DB >> 15747748

A model of spectral filtering to reduce photochemical damage in age-related macular degeneration.

Sanford M Meyers1, Mikhail A Ostrovsky, Robert F Bonner.   

Abstract

BACKGROUND/
PURPOSE: Cumulative sunlight exposure and cataract surgery are reported risk factors for advanced age-related macular degeneration (AMD). Laboratory studies suggest that accumulation and photochemical reactions of A2E (N-retinylidene-N-retinylethanolamine) and its epoxides, components of lipofuscin, are important in AMD. To relate this data to the clinical setting, we modeled the effects of macular irradiance and spectral filtering on production of A2E and reactive oxygen intermediates (ROIs) in pseudophakic eyes with a clear or "yellow" intraocular lens (IOL) and in phakic eyes.
METHODS: We calculated relative changes of macular irradiance as a function of light (390 to 700 nm) intensity, pupil size, age, and lens status, and modeled resulting all-trans-retinal concentration and rates of production of A2E-related photochemicals and photon-induced ROIs in rods and retinal pigment epithelium (RPE). We compared these photoproducts following cataract surgery and IOL implantation with and without spectral sunglasses to normal age-related nuclear sclerotic lens changes.
RESULTS: Following cataract and IOL surgery, all-trans-retinal and lipofuscin photochemistry would theoretically increase average generation of 1) A2E-related photochemicals, 2) ROI in rods and 3) ROI in RPE, respectively, 2.6-, 15- and 6.6-fold with a clear IOL, and 2.1-, 4.1- and 2.6 fold with a yellow IOL, but decrease approximately 30-, approximately 20- and 4-fold with a vermillion filter sunglass and clear IOL compared to an average 70 year old phakic eye.
CONCLUSION: Sunglasses that strongly decrease both deep blue light and rod photobleaching, while preserving photopic sensitivity and color perception, would provide upstream protection from potential photochemical damage in subjects at risk for AMD progression after cataract surgery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15747748      PMCID: PMC1280090     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  32 in total

1.  Light adaptation and dark adaptation of human rod photoreceptors measured from the a-wave of the electroretinogram.

Authors:  M M Thomas; T D Lamb
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

Review 2.  Spare the rods, save the cones in aging and age-related maculopathy.

Authors:  C A Curcio; C Owsley; G R Jackson
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-07       Impact factor: 4.799

3.  How much blue light should an IOL transmit?

Authors:  M A Mainster; J R Sparrow
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

4.  Action spectra for the photoconsumption of oxygen by human ocular lipofuscin and lipofuscin extracts.

Authors:  Anna Pawlak; Małgorzata Rózanowska; Mariusz Zareba; Laura E Lamb; John D Simon; Tadeusz Sarna
Journal:  Arch Biochem Biophys       Date:  2002-07-01       Impact factor: 4.013

5.  Isomerization and oxidation of vitamin a in cone-dominant retinas: a novel pathway for visual-pigment regeneration in daylight.

Authors:  Nathan L Mata; Roxana A Radu; Richard C Clemmons; Gabriel H Travis
Journal:  Neuron       Date:  2002-09-26       Impact factor: 17.173

6.  Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects.

Authors:  F C Delori; D G Goger; C K Dorey
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-07       Impact factor: 4.799

7.  Comparison of the aerobic photoreactivity of A2E with its precursor retinal.

Authors:  Anna Pawlak; Marta Wrona; Malgorzata Rózanowska; Mariusz Zareba; Laura E Lamb; Joan E Roberts; John D Simon; Tadeusz Sarna
Journal:  Photochem Photobiol       Date:  2003-03       Impact factor: 3.421

8.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-10

9.  Involvement of oxidative mechanisms in blue-light-induced damage to A2E-laden RPE.

Authors:  Janet R Sparrow; Jilin Zhou; Shimon Ben-Shabat; Heidi Vollmer; Yasuhiro Itagaki; Koji Nakanishi
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

10.  Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies.

Authors:  Jie Jin Wang; Ronald Klein; Wayne Smith; Barbara E K Klein; Sandy Tomany; Paul Mitchell
Journal:  Ophthalmology       Date:  2003-10       Impact factor: 12.079

View more
  6 in total

1.  [Spectral transmission in blue filter intraocular lenses].

Authors:  N Schrage
Journal:  Ophthalmologe       Date:  2012-02       Impact factor: 1.059

2.  Measurements of transmission spectrums and estimation of retinal blue-light irradiance values of currently available clear and yellow-tinted intraocular lenses.

Authors:  Masaki Tanito; Tsutomu Okuno; Yoshihisa Ishiba; Akihiro Ohira
Journal:  Jpn J Ophthalmol       Date:  2011-11-19       Impact factor: 2.447

3.  Locally learning biomedical data using diffusion frames.

Authors:  M Ehler; F Filbir; H N Mhaskar
Journal:  J Comput Biol       Date:  2012-10-26       Impact factor: 1.479

4.  Violet and blue light blocking intraocular lenses: photoprotection versus photoreception.

Authors:  M A Mainster
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

5.  Modeling Photo-Bleaching Kinetics to Create High Resolution Maps of Rod Rhodopsin in the Human Retina.

Authors:  Martin Ehler; Julia Dobrosotskaya; Denise Cunningham; Wai T Wong; Emily Y Chew; Wojtek Czaja; Robert F Bonner
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

6.  Removal of the blue component of light significantly decreases retinal damage after high intensity exposure.

Authors:  Javier Vicente-Tejedor; Miguel Marchena; Laura Ramírez; Diego García-Ayuso; Violeta Gómez-Vicente; Celia Sánchez-Ramos; Pedro de la Villa; Francisco Germain
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.